NextCure, Inc. — Director's Dealing 2026

Feb 3, 2026

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NextCure, Inc. (NXTC)
CIK: 0001661059
Period of Report: 2026-01-30

Reporting Person: Mayer Timothy (N/A)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2026-01-30	Employee Stock Option (Right to Buy)	$10.85	A	14670	Acquired	2036-01-29	Common Stock (14670)	Direct

Footnotes

F1: One fourth of the option vests on January 30, 2027. The remainder vests in 36 monthly installments beginning on February 28, 2027.